15 August 2019
Dividend Declaration
14 August 2019
Interim Management Statement for the six months ended 30 June 2019…
Calquence granted US Breakthrough Therapy Designation for chronic lymphocytic leukaemia…
Directorate Change
Interim Accounts 30th June 2019…
New corporate name for M&GPrudential at demerger…
13 August 2019
Proposed Cancellation and Repayment to Preference Shareholders…
12 August 2019
SSE statement on discussions relating to possible sale of SSE Energy Services…